Swiss Cancer Institute/AstraZeneca Transform Care Award

Projects must be research-projects focused on improving clinical care pathways in oncology or hematology and demonstrate potential for systemic impact in Switzerland. Projects may be planned or ongoing and can be a distinct workstream within a larger initiative, provided the submitted component contributes substantially to an overarching care transformation goal. Projects demonstrate clear potential to scale beyond a single site, improve equity and efficiency of care, and generate outcomes-oriented evidence suitable for dissemination and policy dialogue. 

Out of Scope Projects  

• Basic science projects without direct, near-term clinical pathway impact 
• Projects lacking measurable outcomes or feasibility within 24 months 
• Projects centered on non-oncology indications or conducted primarily outside Switzerland 
• Projects centered on non-clinically validated technology solutions 

Full applications shall include: 

• Project proposal (see Eligible Projects) max. 5 pages including the rationale, methodology, feasibility, budget and potential impact 
• Curriculum vitae of the candidate 
• Letter of support from the respective head of the candidate’s current institution, incl. guarantee to provide sufficient research time for the project 
• If the candidate institution is not part of the SCI Network, an additional letter of support from the project partner within the SCI network is required. 
• Publication list of the candidate (peer-reviewed original publications) 
• If applicable, any other relevant information or documentation 

Please submit your application by April 27, 2026.

Applications must be submitted electronically to the Swiss Cancer Institute, events@swisscancerinstitute.ch .

In collaboration with AstraZeneca